Griškevičius L - Search Results

1

Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation.

Janavičius R, Rudaitis V, Feng BJ, Ozolina S, Griškevičius L, Goldgar D, Tihomirova L. Janavičius R, et al. Among authors: griskevicius l. Eur J Med Genet. 2013 Mar;56(3):125-30. doi: 10.1016/j.ejmg.2012.12.007. Epub 2012 Dec 27. Eur J Med Genet. 2013. PMID: 23274591

2

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.

Tettero JM, Al-Badri WKW, Ngai LL, Bachas C, Breems DA, van Elssen CHMJ, Fischer T, Gjertsen BT, van Gorkom GNY, Gradowska P, Greuter MJE, Griskevicius L, Juliusson G, Maertens J, Manz MG, Pabst T, Passweg J, Porkka K, Löwenberg B, Ossenkoppele GJ, Janssen JJWM, Cloos J. Tettero JM, et al. Among authors: griskevicius l. Front Oncol. 2022 Oct 10;12:999822. doi: 10.3389/fonc.2022.999822. eCollection 2022. Front Oncol. 2022. PMID: 36300090 Free PMC article.

3

Microsatellite instability detection by high-resolution melting analysis.

Janavicius R, Matiukaite D, Jakubauskas A, Griskevicius L. Janavicius R, et al. Among authors: griskevicius l. Clin Chem. 2010 Nov;56(11):1750-7. doi: 10.1373/clinchem.2010.150680. Epub 2010 Sep 17. Clin Chem. 2010. PMID: 20852132

4

Apparently "BRCA-related" breast and ovarian cancer patient with germline TP53 mutation.

Janavičius R, Andrėkutė K, Mickys U, Rudaitis V, Brasiūnienė B, Griškevičius L. Janavičius R, et al. Among authors: griskevicius l. Breast J. 2011 Jul-Aug;17(4):409-15. doi: 10.1111/j.1524-4741.2011.01088.x. Epub 2011 Apr 28. Breast J. 2011. PMID: 21535297

5

Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania.

Janavičius R, Rudaitis V, Mickys U, Elsakov P, Griškevičius L. Janavičius R, et al. Among authors: griskevicius l. Cancer Genet. 2014 May;207(5):195-205. doi: 10.1016/j.cancergen.2014.05.002. Epub 2014 May 10. Cancer Genet. 2014. PMID: 25066507

6

BRCA1/2 mutation status is an independent factor of improved survival for advanced (stage III-IV) ovarian cancer.

Rudaitis V, Zvirblis T, Kanopiene D, Janulynaite D, Griskevicius L, Janavicius R. Rudaitis V, et al. Among authors: griskevicius l. Int J Gynecol Cancer. 2014 Oct;24(8):1395-400. doi: 10.1097/IGC.0000000000000247. Int J Gynecol Cancer. 2014. PMID: 25248112

7

Extremely low risk of pheochromocytomas in complete VHL gene deletion cases.

Janavicius R, Adomaitis R, Jankevicius F, Griskevicius L. Janavicius R, et al. Among authors: griskevicius l. Hum Mutat. 2009 Sep;30(9):1365-6; author reply 1367. doi: 10.1002/humu.21050. Hum Mutat. 2009. PMID: 19623534 No abstract available.

8

Haplotype-specific sequencing reveals a novel HLA-A*03 allele, A*030114.

Jakubauskas A, Griskevicius L. Jakubauskas A, et al. Among authors: griskevicius l. Tissue Antigens. 2010 Jul;76(1):71-2. doi: 10.1111/j.1399-0039.2010.01457.x. Epub 2010 Feb 4. Tissue Antigens. 2010. PMID: 20136775

9

A novel de novo 2.5 Mb microdeletion of 7q22.1 harbours candidate gene for neurobehavioural disorders and mental retardation.

Dirse V, Burnyte B, Gineikiene E, Griskevicius L, Utkus A. Dirse V, et al. Among authors: griskevicius l. J Genet. 2014 Aug;93(2):501-3. doi: 10.1007/s12041-014-0369-9. J Genet. 2014. PMID: 25189247 No abstract available.

10

Identification of a novel HLA-B allele, B*56:31, by sequence-based typing in a Lithuanian individual.

Jakubauskas A, Vilkeviciene R, Juskevicius D, Griskevicius L. Jakubauskas A, et al. Among authors: griskevicius l. Tissue Antigens. 2011 Mar;77(3):262-3. doi: 10.1111/j.1399-0039.2010.01619.x. Tissue Antigens. 2011. PMID: 21299538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters